Abstract:Nine quinoline‐1,2,4‐triazine hybrids (5 a–5 i) were designed, synthesized, and evaluated as anti‐cancer agents. Compound 5 a, 5 d and 5 h had studied by single crystal x‐ray diffraction. The study of anti‐proliferative activity against Panc‐1 cells has found that compound 5 g exhibited the best anti‐proliferative activity with IC50 value of 26.8 μM. Nine quinoline‐1,2,4‐triazine hybrids (5 a–5 i) were designed, synthesized, and subjected to evaluation as potential anti‐cancer agents. Structures validation of the synthesized analogues was accomplished through comprehensive analysis employing NMR, HRMS, and IR spectroscopy techniques. Furthermore, the molecular structures of compounds 5 a, 5 d and 5 h were authenticated via single crystal X‐ray diffraction. In an extensive screening process against the human pancreatic cancer PANC‐1 cell line utilizing the MTT assay, all quinoline‐1,2,4‐triazine hybrids (5 a–5 i) manifested significant anti‐proliferative activity. Compound 5 g demonstrated a significant anti‐proliferative effect with an IC50 value of 26.8 μM, similar to the positive control, 5‐Fu. Subsequent investigations revealed varying degrees of cell viability in MDA‐MB‐231, A549, and UM‐UC‐3 cell lines upon exposure to different concentrations of compound 5 g. These findings lead us to postulate that compound 5 g may impede the migration, invasion, and adhesion of PANC‐1 cells, similar to the effects observed with 5‐Fu.

Facile synthesis and anti-proliferative activity evaluation of quinoxaline derivatives

Synthesis and Pesticidal Activities of New Quinoxalines

Synthesis, Spectroscopy Properties And Antifungal Activity Of New Quinoxaline Derivatives

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Design and synthesis of unsymmetric benzils, quinoxalines, and evaluations of their anticancer activities against human non‐small lung cancer cells

Novel 5-Methyl-2,4-disubstitued-oxazole Derivatives: Synthesis and Anticancer Activity

Design, Synthesis, Antifungal, and Antioxidant Activities of (E)-6-((2-phenylhydrazono)methyl)quinoxaline Derivatives.

Synthesis, Molecular Modeling and Biological Evaluation of 2-Aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3h)-thione Quinolone Derivatives As Novel Anticancer Agent

Synthesis, Molecular Modeling, and Biological Evaluation of Quinazoline Derivatives Containing the 1,3,4-Oxadiazole Scaffold As Novel Inhibitors of VEGFR2

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids

Novel 2,4,5-Trisubstituted Oxazole Derivatives: Synthesis and Antiproliferative Activity

Novel Penta-1,4-Diene-3-One Derivatives Containing Quinazoline And Oxime Ether Fragments: Design, Synthesis And Bioactivity

Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety

Design, synthesis, and evaluation of antitumor activity of quinazoline derivatives containing different terminal segments of basic amine groups

Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases

Synthesis of Antitumor 3,4,6,7-Tetrahydro-2h-pyrimido[1,6-c]quinazolin-2-imine Derivatives Via Reductive Dearomatization-Initiated Intramolecular Cyclization

Synthesis and Cytotoxicity Evaluation of Some Isoquinoline Derivatives Related to 1-Arylnaphthalene Lignans

Synthesis and Evaluation of 4(3H) -Quinazolinone Derivatives Bearing Aromatic Amine Side Chains As Antitumor Agents